23 September 2015 - CADTH has received notice of a pending submission from Merck for grazoprevir with elbasvir for use by patients with chronic hepatitis C virus infection. For information about the patient input process or for additional instructions, please see the patient input page of the CADTH website.

For more details, go to: https://www.cadth.ca/grazoprevirelbasvir